These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6762734)

  • 21. [Definition of immunologic risk in kidney transplantation].
    Lanzer G
    Fortschr Med; 1987 May; 105(16):309-10. PubMed ID: 3301600
    [No Abstract]   [Full Text] [Related]  

  • 22. Automated reading of the microcytotoxicity test.
    Siauw PA; Lim E; Hardy S; Tayag N; Gjertson D; Terasaki PI
    Clin Transpl; 1989; ():457-62. PubMed ID: 2484858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA typing of cultured amniotic fluid cells.
    Whitsett CF; Priest JH; Priest RE; Marion J
    Am J Clin Pathol; 1983 Feb; 79(2):186-94. PubMed ID: 6823903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of kidney transplantation in relation to HLA-A, B, DR matching and quality of donor organ.
    Lenhard V; Dreikorn K; Röhl L
    Proc Eur Dial Transplant Assoc; 1980; 17():450-6. PubMed ID: 7017689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet?
    Iacomini J; Sayegh MH
    J Am Soc Nephrol; 2006 Feb; 17(2):328-30. PubMed ID: 16382014
    [No Abstract]   [Full Text] [Related]  

  • 27. HLA typing of nonviable tissues with a multiple microabsorption method.
    Westphal E; Heidemann H; Müller-Ruchholtz W
    Diagn Immunol; 1984; 2(2):122-7. PubMed ID: 6499375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretransplant immunologic reactivity to donor lymphocytes--lack of correlation with posttransplant events.
    Keown PA; Stiller CR; Bloch M; Sinclair NR; Lockwood BA; Howson WH
    Transplant Proc; 1981 Sep; 13(3):1563-4. PubMed ID: 7029815
    [No Abstract]   [Full Text] [Related]  

  • 29. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA standardization and proficiency testing in the Southeastern organ Procurement Foundation.
    Heise ER; Biegel AA; MacQueen M
    Transplantation; 1982 Mar; 33(3):233-6. PubMed ID: 7039031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometry crossmatching and primary cadaver kidney graft outcome: relevance of T and B cell targets, historic sera and autologous controls.
    LeFor WM; Ackermann JR; Alveranga DY; Bowers VD; Heinrichs DF; Kahana L; Shires DL; Weinstein SS; Wright CE
    Clin Transplant; 1996 Dec; 10(6 Pt 2):601-6. PubMed ID: 8996750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crossmatching considerations in renal transplantation.
    Kiran AL; Vijayalakshmi V; Murthy KJ; Sahariah S
    J Assoc Physicians India; 1996 Aug; 44(8):521-4. PubMed ID: 9251421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of pre- and postgraft antibodies against endothelial cells (umbilical cord) in kidney allografts.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1981 Sep; 13(3):1551-5. PubMed ID: 7029813
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical applications of HLA testing.
    Braun WE
    IMJ Ill Med J; 1982 Sep; 162(3):219-24. PubMed ID: 6129224
    [No Abstract]   [Full Text] [Related]  

  • 37. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report.
    Heo WB; Kim CD; Won DI
    Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search for standard HLA reagents.
    Vox Sang; 1976 Nov; 31(5):380-5. PubMed ID: 1007161
    [No Abstract]   [Full Text] [Related]  

  • 40. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
    Duquesnoy RJ; Claas FH
    Tissue Antigens; 2007 Apr; 69 Suppl 1():180-4. PubMed ID: 17445196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.